Onglyza 2.5 mg

Onglyza 2.5 mg tablets contain saxagliptin, a DPP-4 inhibitor used to manage type 2 diabetes. This oral medication helps regulate blood sugar levels when combined with diet and exercise.

Onglyza 2.5 mg tablets are primarily used to manage type 2 diabetes in adults. Saxagliptin works by increasing insulin levels and decreasing glucose production in the liver, helping to control blood sugar. This medication is often prescribed alongside diet and exercise to improve glycemic control. What is Onglyza used for? It is typically used as an adjunct therapy for type 2 diabetes management.

Common effects of Onglyza 2.5 mg tablets may include headache, upper respiratory tract infection, and nasopharyngitis. Some users might experience gastrointestinal discomfort or mild allergic reactions. These effects vary among individuals and are not exhaustive. Always consult a healthcare provider for personalized advice.

Onglyza 2.5 mg tablets should be handled with care, especially by individuals with a history of pancreatitis, kidney issues, or allergies. It is important to follow the prescribed dosage and monitor blood sugar levels regularly. Pregnant or breastfeeding women should consult a healthcare provider before use.

Onglyza 2.5 mg tablets may interact with certain medications, including insulin, other diabetes drugs, and CYP3A4 inhibitors or inducers. Alcohol consumption should be moderated, as it can affect blood sugar levels. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.